Related Experiment Video
Updated: Aug 4, 2026

Listeria monocytogenes Infection of the Brain
Published on: October 2, 2018
Listeria spinal cord abscess responsive to trimethoprim-sulfamethoxazole monotherapy
F H Rossi1, J White, R Quisling
1Department of Neurology, University of Florida, Gainesville, USA.
Objective:
To describe an alternative antibiotic regimen for the treatment of central nervous system Listeria monocytogenes infection.
Background:
Classical treatment of listeria infections of the brain and spinal cord has included ampicillin in combination with gentamicin and chloramphenicol. Antibiotic resistance to L. monocytogenes is extraordinarily low, and the combined risks of nephrotoxicity, ototoxicity, and agranulocytosis in an already critically ill patient make the potential use of trimethoprim-sulfamethoxazole monotherapy for coverage or treatment of listeria an important alternative.
Methods:
Case report.
Results:
A 58-year-old woman presented with a two-week history of progressive quadriplegia. Gadolinium enhanced MRI showed diffuse edema of the cervical and thoracic spine with ring-enhancing lesions. Cerebrospinal fluid and blood cultures both grew L. monocytogenes. Spinal cord biopsy of the lesion revealed inflammation with necrosis and also grew listeria. Intravenous trimethoprim-sulfamethoxazole (8 mg/kg in four divided doses) was administered for six weeks with resultant arrest of neurological symptoms and stabilization of the clinical course. Although the patient was quadraparetic she was able to be discharged to a rehabilitation facility.
Conclusions:
Trimethoprim-sulfamethoxazole monotherapy may be a potential alternative option for critically ill patients with central nervous system L. monocytogenes infection.
Insights
Trimethoprim-sulfamethoxazole monotherapy offers a promising alternative for treating central nervous system Listeria monocytogenes infections. This approach may be suitable for critically ill patients, potentially reducing risks associated with traditional combination therapies.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Central nervous system Listeria monocytogenes infections traditionally treated with ampicillin, gentamicin, and chloramphenicol.
- Established therapies carry risks of nephrotoxicity, ototoxicity, and agranulocytosis.
- Low antibiotic resistance in L. monocytogenes suggests alternative monotherapy options.
Observation:
- A 58-year-old female presented with progressive quadriplegia and spinal cord lesions.
- Cerebrospinal fluid, blood, and spinal cord biopsy cultures confirmed L. monocytogenes infection.
- MRI revealed diffuse cervical and thoracic spine edema with ring-enhancing lesions.
Findings:
- Intravenous trimethoprim-sulfamethoxazole monotherapy (8 mg/kg every 6 hours for 6 weeks) was administered.
- The patient experienced arrest of neurological symptoms and clinical stabilization.
- Neurological deficits improved, allowing discharge to a rehabilitation facility.
Implications:
- Trimethoprim-sulfamethoxazole monotherapy presents a viable alternative for CNS L. monocytogenes infections.
- This regimen may be particularly beneficial for critically ill patients.
- Further research could validate trimethoprim-sulfamethoxazole as a standard alternative treatment.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Viral Meningitis
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis I: Introduction
Brain Abscess l: Introduction

